ANALYST PROFILE
Emily Field, CFA
Barclays
Wall Street AnalystFirst retained rating 2023-10-02Last retained rating 2026-09-18
- Rated companies
- 10
- Tracked ratings
- 78
Rating Distribution
78Tracked ratingsSuccess Rate
(m)
Average return: (m)
Dividend-reinvested directional calls
Emily Field, CFA, Barclays
Barclays names Emily Field, CFA as its analyst on 10 stocks (HELP, AMGN, CYTK and 7 more), with 78 dated ratings. The newest: Overweight on HELP on 2026-09-18.
- 2026-09-18: Stock HELP; Analyst Emily Field, CFA; Firm Barclays; Price When Rated $14.02; Price Target $35.00; Upside / Downside +149.64%.
- 2026-08-13: Stock AMGN; Analyst Emily Field, CFA; Firm Barclays; Price When Rated $416.18; Price Target $380.00; Upside / Downside -8.69%.
- 2026-08-13: Stock CYTK; Analyst Emily Field, CFA; Firm Barclays; Price When Rated $75.64; Price Target $110.00; Upside / Downside +45.43%.
- 2026-07-28: Stock ABBV; Analyst Emily Field, CFA; Firm Barclays; Price When Rated $256.91; Price Target $300.00; Upside / Downside +16.77%.
Ratings as Barclays publishes them in its public rating disclosure, newest first, on each stock where the firm currently names Emily Field, CFA as its analyst. An older rating may predate their coverage. Performance is each stock's share price change from its close on the rating date (or the last close before it) to its latest retained close on 2026-09-24, restated for splits; price only, dividends not included. A dash marks a rating from before the retained closes begin (2025-05-09, or later for a stock listed since), or a price move no recorded split explains.
| Date | Stock | Analyst | Firm | Price When Rated | Price Target | Upside / Downside | Rating | Performance |
|---|---|---|---|---|---|---|---|---|
| 2026-09-18 | HELP CYBIN INC. | Emily Field, CFA | Barclays | $14.02 | $35.00 | +149.64% | Overweight | +1.66% |
| 2026-08-13 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $416.18 | $380.00 | -8.69% | Equal Weight | -2.80% |
| 2026-08-13 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $75.64 | $110.00 | +45.43% | Overweight | -10.57% |
| 2026-07-28 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $256.91 | $300.00 | +16.77% | Overweight | +0.60% |
| 2026-07-28 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $376.26 | $360.00 | -4.32% | Equal Weight | +3.33% |
| 2026-07-28 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $200.14 | $200.00 | -0.07% | Equal Weight | +9.83% |
| 2026-07-28 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $130.52 | $145.00 | +11.09% | Equal Weight | +11.37% |
| 2026-07-28 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $130.76 | $150.00 | +14.71% | Overweight | +12.29% |
| 2026-05-04 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $963.33 | $1,400.00 | +45.33% | Overweight | +22.23% |
| 2026-04-02 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $66.61 | $95.00 | +42.62% | Overweight | -1.57% |
| 2026-02-19 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $232.86 | $275.00 | +18.10% | Overweight | +18.07% |
| 2026-02-19 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $373.36 | $350.00 | -6.26% | Equal Weight | +8.18% |
| 2026-02-19 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $195.62 | $185.00 | -5.43% | Equal Weight | +17.92% |
| 2026-02-19 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $60.35 | $75.00 | +24.28% | Overweight | +2.02% |
| 2026-02-19 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $155.27 | $155.00 | -0.17% | Equal Weight | -0.98% |
| 2026-02-19 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $1,036.05 | $1,350.00 | +30.30% | Overweight | +15.65% |
| 2026-02-19 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $121.57 | $140.00 | +15.16% | Overweight | +21.47% |
| 2026-02-19 | PFE PFIZER INC | Emily Field, CFA | Barclays | $27.37 | $25.00 | -8.66% | Underweight | +5.85% |
| 2025-12-21 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $62.72 | $87.00 | +38.71% | Overweight | +4.85% |
| 2025-10-06 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $56.97 | $82.00 | +43.94% | Overweight | +8.35% |
| 2025-09-02 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $49.62 | $71.00 | +43.09% | Overweight | +32.40% |
| 2025-05-07 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $33.97 | $53.00 | +56.02% | Overweight | |
| 2025-04-24 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $38.00 | $55.00 | +44.74% | Overweight | |
| 2024-11-29 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $183.08 | Overweight | |||
| 2024-11-29 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $280.07 | Equal Weight | |||
| 2024-11-29 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $159.83 | Equal Weight | |||
| 2024-11-29 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $59.27 | Underweight | |||
| 2024-11-29 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $52.22 | Overweight | |||
| 2024-11-29 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $92.41 | Equal Weight | |||
| 2024-11-29 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $788.19 | Overweight | |||
| 2024-11-29 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $103.12 | Overweight | |||
| 2024-11-29 | PFE PFIZER INC | Emily Field, CFA | Barclays | $25.83 | Equal Weight | |||
| 2024-11-06 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $90.22 | $95.00 | +5.30% | Equal Weight | |
| 2024-10-30 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $183.47 | $180.00 | -1.89% | Equal Weight | |
| 2024-10-30 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $903.58 | $975.00 | +7.90% | Overweight | |
| 2024-10-04 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $195.45 | $212.00 | +8.47% | Overweight | |
| 2024-10-04 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $317.48 | $315.00 | -0.78% | Equal Weight | |
| 2024-10-04 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $54.20 | $43.00 | -20.66% | Underweight | |
| 2024-10-04 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $84.17 | $84.00 | -0.20% | Equal Weight | |
| 2024-10-04 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $110.18 | $140.00 | +27.06% | Overweight | |
| 2024-08-21 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $48.98 | $42.00 | -14.25% | Underweight | |
| 2024-08-01 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $213.20 | $190.00 | -10.88% | Equal Weight | |
| 2024-07-30 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $127.78 | $142.00 | +11.13% | Overweight | |
| 2024-07-30 | PFE PFIZER INC | Emily Field, CFA | Barclays | $30.72 | $32.00 | +4.17% | Equal Weight | |
| 2024-07-29 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $50.45 | Underweight | |||
| 2024-07-25 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $182.17 | $200.00 | +9.79% | Overweight | |
| 2024-07-10 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $40.86 | $41.00 | +0.34% | Equal Weight | |
| 2024-07-10 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $932.50 | $1,025.00 | +9.92% | Overweight | |
| 2024-07-10 | PFE PFIZER INC | Emily Field, CFA | Barclays | $27.72 | $30.00 | +8.23% | Equal Weight | |
| 2024-05-22 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $60.14 | $95.00 | +57.96% | Overweight | |
| 2024-05-03 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $278.39 | $300.00 | +7.76% | Equal Weight | |
| 2024-04-30 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $781.10 | $913.00 | +16.89% | Overweight | |
| 2024-04-29 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $159.62 | $187.00 | +17.15% | Overweight | |
| 2024-04-29 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $65.94 | $76.00 | +15.26% | Equal Weight | |
| 2024-04-25 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $44.70 | $43.00 | -3.80% | Equal Weight | |
| 2024-04-24 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $201.99 | $200.00 | -0.99% | Equal Weight | |
| 2024-04-03 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $206.38 | $215.00 | +4.18% | Equal Weight | |
| 2024-03-26 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $178.53 | $195.00 | +9.23% | Overweight | |
| 2024-02-15 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $223.35 | $230.00 | +2.98% | Equal Weight | |
| 2024-02-12 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $74.45 | $80.00 | +7.45% | Equal Weight | |
| 2024-02-07 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $725.38 | $810.00 | +11.67% | Overweight | |
| 2024-02-04 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $168.67 | $185.00 | +9.68% | Overweight | |
| 2024-02-01 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $126.38 | $145.00 | +14.73% | Overweight | |
| 2024-01-22 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $164.77 | $175.00 | +6.21% | Overweight | |
| 2024-01-22 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $78.43 | $85.00 | +8.38% | Equal Weight | |
| 2024-01-22 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $630.88 | $680.00 | +7.79% | Overweight | |
| 2024-01-22 | MRK Merck & Co., Inc. | Emily Field, CFA | Barclays | $119.43 | $135.00 | +13.04% | Overweight | |
| 2023-12-27 | CYTK CYTOKINETICS INC | Emily Field, CFA | Barclays | $83.44 | $100.00 | +19.85% | Overweight | |
| 2023-12-13 | PFE PFIZER INC | Emily Field, CFA | Barclays | $26.66 | $28.00 | +5.03% | Equal Weight | |
| 2023-11-08 | BIIB BIOGEN INC. | Emily Field, CFA | Barclays | $231.69 | $255.00 | +10.06% | Equal Weight | |
| 2023-11-07 | GILD GILEAD SCIENCES, INC. | Emily Field, CFA | Barclays | $80.61 | $82.00 | +1.72% | Equal Weight | |
| 2023-11-02 | LLY ELI LILLY & Co | Emily Field, CFA | Barclays | $580.29 | $630.00 | +8.57% | Overweight | |
| 2023-10-31 | PFE PFIZER INC | Emily Field, CFA | Barclays | $30.56 | $34.00 | +11.26% | Equal Weight | |
| 2023-10-30 | ABBV AbbVie Inc. | Emily Field, CFA | Barclays | $138.93 | $170.00 | +22.36% | Overweight | |
| 2023-10-26 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $52.97 | $51.00 | -3.72% | Equal Weight | |
| 2023-10-02 | AMGN AMGEN INC | Emily Field, CFA | Barclays | $268.76 | $230.00 | -14.42% | Underweight | |
| 2023-10-02 | BMY BRISTOL MYERS SQUIBB CO | Emily Field, CFA | Barclays | $57.85 | $60.00 | +3.72% | Equal Weight | |
| 2023-10-02 | PFE PFIZER INC | Emily Field, CFA | Barclays | $33.94 | $35.00 | +3.12% | Equal Weight |
Similar Analysts
| Analyst | Firm | Ratings | Stocks |
|---|---|---|---|
| Not available yet | |||